347 related articles for article (PubMed ID: 33706868)
21. A Meta-Analysis Comparing Aspirin Alone Versus Dual Antiplatelet Therapy for the Prevention of Venous Graft Failure Following Coronary Artery Bypass Surgery.
Hesterberg K; Rawal A; Khan S; Rashid A; Jones D; Siddiqui T; Khader TA; Nayyar M; Shah R
Cardiovasc Revasc Med; 2020 Jun; 21(6):792-796. PubMed ID: 31672535
[TBL] [Abstract][Full Text] [Related]
22. Postoperative Bleeding Following Preoperative Clopidogrel Administration in Patients with Haemoglobin Level Above 110 g/L Undergoing Urgent CABG.
Kacar SM; Mikic A; Kačar MB
Braz J Cardiovasc Surg; 2018; 33(1):59-63. PubMed ID: 29617503
[TBL] [Abstract][Full Text] [Related]
23. Platelet inhibition and bleeding complications in cardiac surgery: A review.
Hansson EC; Jeppsson A
Scand Cardiovasc J; 2016; 50(5-6):349-354. PubMed ID: 27590033
[TBL] [Abstract][Full Text] [Related]
24. Effect of Ticagrelor Plus Aspirin, Ticagrelor Alone, or Aspirin Alone on Saphenous Vein Graft Patency 1 Year After Coronary Artery Bypass Grafting: A Randomized Clinical Trial.
Zhao Q; Zhu Y; Xu Z; Cheng Z; Mei J; Chen X; Wang X
JAMA; 2018 Apr; 319(16):1677-1686. PubMed ID: 29710164
[TBL] [Abstract][Full Text] [Related]
25. Smoking and outcomes following guided de-escalation of antiplatelet treatment in acute coronary syndrome patients: a substudy from the randomized TROPICAL-ACS trial.
Orban M; Trenk D; Geisler T; Rieber J; Hadamitzky M; Gross L; Orban M; Kupka D; Baylacher M; Müller S; Huber K; Koltowski L; Huczek Z; Heyn J; Jacobshagen C; Aradi D; Massberg S; Sibbing D; Hein R;
Eur Heart J Cardiovasc Pharmacother; 2020 Nov; 6(6):372-381. PubMed ID: 31855244
[TBL] [Abstract][Full Text] [Related]
26. Platelet function measurement-based strategy to reduce bleeding and waiting time in clopidogrel-treated patients undergoing coronary artery bypass graft surgery: the timing based on platelet function strategy to reduce clopidogrel-associated bleeding related to CABG (TARGET-CABG) study.
Mahla E; Suarez TA; Bliden KP; Rehak P; Metzler H; Sequeira AJ; Cho P; Sell J; Fan J; Antonino MJ; Tantry US; Gurbel PA
Circ Cardiovasc Interv; 2012 Apr; 5(2):261-9. PubMed ID: 22396581
[TBL] [Abstract][Full Text] [Related]
27. Dual antiplatelet therapy in patients requiring urgent coronary artery bypass grafting surgery: a position statement of the Canadian Cardiovascular Society.
Fitchett D; Eikelboom J; Fremes S; Mazer D; Singh S; Bittira B; Brister S; Graham J; Gupta M; Karkouti K; Lee A; Love M; McArthur R; Peterson M; Verma S; Yau T
Can J Cardiol; 2009 Dec; 25(12):683-9. PubMed ID: 19960127
[TBL] [Abstract][Full Text] [Related]
28. Platelet Inhibition and Bleeding in Patients Undergoing Non-Cardiac Surgery-The BIANCA Observational Study.
Mahla E; Metzler H; Bornemann-Cimenti H; Prueller F; Raggam RB; Pregartner G; Berghold A; Baumann A; Goeroeg C; Gurbel PA
Thromb Haemost; 2018 May; 118(5):864-872. PubMed ID: 29625498
[TBL] [Abstract][Full Text] [Related]
29. Factors influencing platelet reactivity in patients undergoing coronary artery bypass surgery.
Schneider DJ; Chava S
Coron Artery Dis; 2016 May; 27(3):185-90. PubMed ID: 26751426
[TBL] [Abstract][Full Text] [Related]
30. Safety of Preoperative Use of Ticagrelor With or Without Aspirin Compared With Aspirin Alone in Patients With Acute Coronary Syndromes Undergoing Coronary Artery Bypass Grafting.
Gherli R; Mariscalco G; Dalén M; Onorati F; Perrotti A; Chocron S; Verhoye JP; Gulbins H; Reichart D; Svenarud P; Faggian G; Santarpino G; Fischlein T; Maselli D; Dominici C; Musumeci F; Rubino AS; Mignosa C; De Feo M; Bancone C; Gatti G; Maschietto L; Santini F; Nicolini F; Gherli T; Zanobini M; Kinnunen EM; Ruggieri VG; Rosato S; Biancari F
JAMA Cardiol; 2016 Nov; 1(8):921-928. PubMed ID: 27653165
[TBL] [Abstract][Full Text] [Related]
31. Major Bleeding after Surgical Revascularization with Dual Antiplatelet Therapy.
Schlachtenberger G; Deppe AC; Gerfer S; Choi YH; Zeriouh M; Liakopoulos O; Wahlers TCW
Thorac Cardiovasc Surg; 2020 Dec; 68(8):714-722. PubMed ID: 32593177
[TBL] [Abstract][Full Text] [Related]
32. Effects of Ticagrelor Versus Clopidogrel in Troponin-Negative Patients With Low-Risk ACS Undergoing Ad Hoc PCI.
Angiolillo DJ; Franchi F; Waksman R; Sweeny JM; Raveendran G; Teng R; Zhao Y; Carlson G; Khan N; Mehran R
J Am Coll Cardiol; 2016 Feb; 67(6):603-613. PubMed ID: 26868683
[TBL] [Abstract][Full Text] [Related]
33. Guanxinning tablet for patients who switch from dual antiplatelet therapy to aspirin alone after percutaneous coronary intervention: study protocol for a cluster randomized controlled trial.
Li J; Ju J; Chen Z; Liu J; Lu F; Gao R; Xu H
Trials; 2018 Feb; 19(1):93. PubMed ID: 29415754
[TBL] [Abstract][Full Text] [Related]
34. Ischemic and bleeding outcomes after coronary artery bypass grafting among patients initially treated with a P2Y
Russo JJ; James TE; Ruel M; Dupuis JY; Singh K; Goubran D; Malhotra N; Rubens F; Chong AY; Hibbert B; Boland P; Tran DT; Tanguay JF; Lordkipanidzé M; Perrault L; Wells GA; Bourke M; Chan V; So DY
Eur Heart J Acute Cardiovasc Care; 2019 Sep; 8(6):543-553. PubMed ID: 29313713
[TBL] [Abstract][Full Text] [Related]
35. Antiplatelet effect of ticagrelor compared to tirofiban in non-ST-segment elevation ACS patients undergoing PCI. The result of the TE-CLOT trial.
Kim JS; Han DC; Jeong YH; Park DW; Sohn CB; Hwang KW; Lee SH; Choi JH; Chon MK; Lee SY; Hwang J; Kim IS; Lee SM; Han J; Noh M; Kim CH; Chun KJ; Park YH; Kim JH
Thromb Haemost; 2016 Jan; 115(1):213-21. PubMed ID: 26581884
[TBL] [Abstract][Full Text] [Related]
36. Predictive value of post-treatment platelet reactivity for occurrence of post-discharge bleeding after non-ST elevation acute coronary syndrome. Shifting from antiplatelet resistance to bleeding risk assessment?
Cuisset T; Cayla G; Frere C; Quilici J; Poyet R; Gaborit B; Bali L; Morange PE; Alessi MC; Bonnet JL
EuroIntervention; 2009 Aug; 5(3):325-9. PubMed ID: 19736156
[TBL] [Abstract][Full Text] [Related]
37. A randomized trial to compare the safety of rivaroxaban vs aspirin in addition to either clopidogrel or ticagrelor in acute coronary syndrome: The design of the GEMINI-ACS-1 phase II study.
Povsic TJ; Roe MT; Ohman EM; Steg PG; James S; Plotnikov A; Mundl H; Welsh R; Bode C; Gibson CM
Am Heart J; 2016 Apr; 174():120-8. PubMed ID: 26995378
[TBL] [Abstract][Full Text] [Related]
38. Efficacy and Safety of Potent Oral P2Y
Ma S; Li Z; Yu P; Song H; Jiang Z; Li Y; Han Y
Cardiovasc Drugs Ther; 2020 Apr; 34(2):199-208. PubMed ID: 32006144
[TBL] [Abstract][Full Text] [Related]
39. Point-of-care platelet function testing predicts bleeding in patients exposed to clopidogrel undergoing coronary artery bypass grafting: Verify pre-op TIMI 45--a pilot study.
Reed GW; Kumar A; Guo J; Aranki S; Shekar P; Agnihotri A; Maree AO; McLean DS; Rosenfield K; Cannon CP
Clin Cardiol; 2015 Feb; 38(2):92-8. PubMed ID: 25655085
[TBL] [Abstract][Full Text] [Related]
40. Ticagrelor versus clopidogrel in patients with acute coronary syndromes undergoing coronary artery bypass surgery: results from the PLATO (Platelet Inhibition and Patient Outcomes) trial.
Held C; Asenblad N; Bassand JP; Becker RC; Cannon CP; Claeys MJ; Harrington RA; Horrow J; Husted S; James SK; Mahaffey KW; Nicolau JC; Scirica BM; Storey RF; Vintila M; Ycas J; Wallentin L
J Am Coll Cardiol; 2011 Feb; 57(6):672-84. PubMed ID: 21194870
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
